scispace - formally typeset
Journal ArticleDOI

European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.

Reads0
Chats0
TLDR
These guidelines provide the most reliable contemporary evidence base for the management of RCC in 2019 and are thoroughly evaluated to establish international standards for the care of kidney cancer patients.
About
This article is published in European Urology.The article was published on 2019-05-01. It has received 965 citations till now. The article focuses on the topics: Guideline & Context (language use).

read more

Citations
More filters
Journal ArticleDOI

Renal cell carcinoma.

TL;DR: An overview of the biology of RCC, with a focus on ccRCC, as well as updates to complement the current clinical guidelines and an outline of potential future directions for RCC research and therapy are provided.
Journal ArticleDOI

Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-up: AUA Guideline: Part II

TL;DR: In this paper, the AUA Guideline focuses on active surveillance and follow-up after intervention for adult patients with clinically-localized renal masses suspicious for cancer, including solid enha...
References
More filters
Journal Article

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.

TL;DR: The QUOROM Statement (QUality Of Reporting Of Meta-analyses) as mentioned in this paper was developed to address the suboptimal reporting of systematic reviews and meta-analysis of randomized controlled trials.
Journal ArticleDOI

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

TL;DR: Overall survival and objective response rates were significantly higher with nivolumab plus ipilimumab than with sunitinib among intermediate‐ and poor‐risk patients with previously untreated advanced renal‐cell carcinoma.
Journal ArticleDOI

The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.

TL;DR: This review summarizes the most significant differences between the newly published classification of urogenital tumours and the prior version for renal, penile, and testicular tumours.
Related Papers (5)